DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ha, SJ | - |
dc.contributor.author | Jeon, BY | - |
dc.contributor.author | Youn, JI | - |
dc.contributor.author | Kim, SC | - |
dc.contributor.author | Cho, SN | - |
dc.contributor.author | Sung, YC | - |
dc.date.accessioned | 2016-04-01T02:13:43Z | - |
dc.date.available | 2016-04-01T02:13:43Z | - |
dc.date.created | 2009-02-28 | - |
dc.date.issued | 2005-04 | - |
dc.identifier.issn | 0969-7128 | - |
dc.identifier.other | 2005-OAK-0000004968 | - |
dc.identifier.uri | https://oasis.postech.ac.kr/handle/2014.oak/24703 | - |
dc.description.abstract | Active disease of tuberculosis ( TB) can be developed decades later by either a relapse of the initial infection ( endogenous reactivation) or by an entrance of the secondary infection ( exogenous reinfection), since the current chemotherapy cannot lead to complete elimination of tuberculosis. Although the immunotherapeutic approaches in conjunction with conventional chemotherapy were tried to prevent TB growth via boosting the immune system, their therapeutic effects are still controversial. Here, we found that TB DNA vaccination completely blocked tuberculosis reactivation and significantly prevented from the secondary infection when chemotherapy was combined simultaneously. In particular, double-gene DNA vaccine composed of Ag85A and PstS-3 genes could reduce bacteria growth better than single-gene DNA vaccine after a secondary reinfection, indicating a correlation between the breadth of Th1 IFN-gamma response and the efficacy of the protection from reinfection. Thus, we propose that multigene TB DNA immunotherapy including Ag85A and PstS-3 genes during the period of chemotherapy could benefit patients undergoing TB chemotherapy in prevention from exogenous reinfection as well as endogenous reactivation. | - |
dc.description.statementofresponsibility | X | - |
dc.language | English | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.relation.isPartOf | GENE THERAPY | - |
dc.subject | mycobacterium tuberculosis | - |
dc.subject | double-gene DNA vaccine | - |
dc.subject | chemotherapy | - |
dc.subject | Ag85A | - |
dc.subject | PstS-3 | - |
dc.subject | EXOGENOUS REINFECTION | - |
dc.subject | MOLECULAR EPIDEMIOLOGY | - |
dc.subject | LATENT TUBERCULOSIS | - |
dc.subject | T-CELLS | - |
dc.subject | IMMUNOGENICITY | - |
dc.subject | INFECTION | - |
dc.subject | IMMUNIZATION | - |
dc.subject | EFFICACY | - |
dc.subject | CD4(+) | - |
dc.subject | MODEL | - |
dc.title | Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis | - |
dc.type | Article | - |
dc.contributor.college | 생명과학과 | - |
dc.identifier.doi | 10.1038/sj.gt.3302465 | - |
dc.author.google | Ha, SJ | - |
dc.author.google | Jeon, BY | - |
dc.author.google | Youn, JI | - |
dc.author.google | Kim, SC | - |
dc.author.google | Cho, SN | - |
dc.author.google | Sung, YC | - |
dc.relation.volume | 12 | - |
dc.relation.issue | 7 | - |
dc.relation.startpage | 634 | - |
dc.relation.lastpage | 638 | - |
dc.contributor.id | 10053752 | - |
dc.relation.journal | GENE THERAPY | - |
dc.relation.index | SCI급, SCOPUS 등재논문 | - |
dc.relation.sci | SCI | - |
dc.collections.name | Journal Papers | - |
dc.type.rims | ART | - |
dc.identifier.bibliographicCitation | GENE THERAPY, v.12, no.7, pp.634 - 638 | - |
dc.identifier.wosid | 000227857500012 | - |
dc.date.tcdate | 2019-02-01 | - |
dc.citation.endPage | 638 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 634 | - |
dc.citation.title | GENE THERAPY | - |
dc.citation.volume | 12 | - |
dc.contributor.affiliatedAuthor | Sung, YC | - |
dc.identifier.scopusid | 2-s2.0-16344395660 | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.wostc | 48 | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | EXOGENOUS REINFECTION | - |
dc.subject.keywordPlus | MOLECULAR EPIDEMIOLOGY | - |
dc.subject.keywordPlus | LATENT TUBERCULOSIS | - |
dc.subject.keywordPlus | T-CELLS | - |
dc.subject.keywordPlus | IMMUNOGENICITY | - |
dc.subject.keywordPlus | INFECTION | - |
dc.subject.keywordPlus | IMMUNIZATION | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | CD4(+) | - |
dc.subject.keywordPlus | MODEL | - |
dc.subject.keywordAuthor | mycobacterium tuberculosis | - |
dc.subject.keywordAuthor | double-gene DNA vaccine | - |
dc.subject.keywordAuthor | chemotherapy | - |
dc.subject.keywordAuthor | Ag85A | - |
dc.subject.keywordAuthor | PstS-3 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
library@postech.ac.kr Tel: 054-279-2548
Copyrights © by 2017 Pohang University of Science ad Technology All right reserved.